NASDAQ: CYTH - Cyclo Therapeutics, Inc.

Lønnsomhet i seks måneder: -8.67%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Cyclo Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

flere detaljer
The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2011-02-23
ISIN US23254X2018
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://cyclotherapeutics.com
Цена ао 0.7206
Prisendring per dag: 0% (0.7206)
Prisendring per uke: +2.94% (0.7)
Prisendring per måned: -6.29% (0.769)
Prisendring over 3 måneder: +20.5% (0.598)
Prisendring over seks måneder: -8.67% (0.789)
Prisendring per år: -48.16% (1.39)
Prisendring over 3 år: -74.72% (2.85)
Prisendring over 5 år: +325.13% (0.1695)
Prisendring siden begynnelsen av året: +19.8% (0.6015)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 9.13 1
P/BV 2.06 7
P/E 0 0
EV/EBITDA -0.0803 0
Total: 4.75

Effektivitet

Navn Betydning Karakter
ROA, % -151.4 0
ROE, % -421.64 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0516 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 19.2 3
Lønnsomhet Ebitda, % 122.56 10
Lønnsomhet EPS, % -77.99 0
Total: 6.4
Flere detaljer

Institusjoner Volum Dele, %
Founders Fund V Management, LLC 480708 1.67
Vanguard Group Inc 355223 1.24
Geode Capital Management, LLC 152077 0.53
Founders Fund VI Management, LLC 110023 0.38
Citadel Advisors Llc 54018 0.19
Blackrock Inc. 48444 0.17
State Street Corporation 39525 0.14
Wealth Enhancement Advisory Services, LLC 18513 0.06
Northern Trust Corporation 17453 0.06
XTX Topco Ltd 10696 0.04

ETFDele, %Lønnsomhet for året, %Utbytte, %
iShares Micro-Cap ETF 0.00344 17.09 1.54048
017.091.54



Veileder Stillingstittel Betaling Fødselsår
Mr. N. Scott Fine CEO & Director 569.92k 1957 (68 år)
Mr. C. E Strattan Founder & Director N/A 1946 (79 år)
Mr. Joshua M. Fine CFO & Secretary 421.17k 1982 (43 år)
Mr. Michael Eric Lisjak Senior VP of Business Development & Chief Regulatory Officer 430.4k 1974 (51 år)
Dr. Jeffrey L. Tate Ph.D. COO, Chief Quality Officer & Director 255.14k 1958 (67 år)
Dr. Karen Mullen FFPM Interim Chief Medical Officer N/A
Ms. Lori McKenna Global Head of Patient Advocacy N/A

Adresse: United States, Gainesville. FL, 6714 NW 16th Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://cyclotherapeutics.com